RSS   Newsletter   Contact   Advertise with us

Sanofi and GSK sign agreements with Canada to supply up to 72 million doses of coronavirus vaccine

Christian Fernsby ▼ | September 23, 2020
Sanofi and GSK signed agreements with the Government of Canada for the supply of up to 72 million doses of an adjuvanted coronavirus vaccine, beginning in 2021.
Doses of coronavirus vaccine   Sanofi
“Today’s announcement showcases our unwavering commitment to develop a COVID-19 vaccine that is available to everyone when it comes to market,” said Thomas Triomphe, Executive Vice President and Global Head of Sanofi Pasteur.

Topics: Sanofi GSK

Roger Connor, President of GSK Vaccines added, "GSK is proud to be working in partnership with Sanofi to make this vaccine available as soon as possible in Canada.”